Purpose. Bloodstream infections are major causes of morbidity and mortality that lead to prolonged hospital stays and higher medical costs. In this study, we aimed to evaluate the MinION nanopore sequencer for the identification of the most dominant pathogens in positive blood culture bottles.
INTRODUCTION
Bloodstream infections (BSIs) are major causes of morbidity and mortality that lead to prolonged hospital stays and higher medical costs [1, 2] . The increasing presence of antimicrobial-resistant pathogens limits the options in terms of appropriate antibiotics and promotes the use of empirical treatments with broad-spectrum antibiotics. Therefore, early identification of the causative pathogen is vital in order to improve patient prognosis and reduce the number of antimicrobial-resistant pathogens.
Direct bacterial and fungal profiling via matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), which reduces the labour input required for subculture of the broth and overnight incubation for obtaining isolated colonies, has recently been introduced as an innovative approach for the identification of bacteria from blood culture media [3, 4] . This simplified MALDI-TOF MS technology has dramatically reduced both the cost and work involved and has become a useful alternative in the rapid diagnosis of BSI. Additionally, it has been reported as a promising and reliable identification tool for various microorganisms, including acid-fast bacilli and fungi cultured from clinical specimens [5, 6] . Thus, MALDI-TOF MS has the potential for use as a routine clinical technology in the rapid identification of a broad range of pathogens, although the high initial cost would unfortunately prohibit its widespread use in frontline clinical settings.
In recent years, certain automated and rapid hybridization-based methods have also become available, including the Verigene Gram-positive and Gram-negative blood culture nucleic acid tests (BC-GP, BC-GN; Nanosphere Inc., Northbrook, IL), which have the advantage of being able to detect the most common bacterial pathogens and potential antibiotic resistance genes directly from blood cultures within 2.5 h. The disadvantage of the Verigene test is that there is a limitation to the types of pathogens detectable [7] . On the other hand, FilmArray Blood Culture Identification Panel (BCID), a recently approved, fully automatic multiplex PCR-based system, has become available (bioM erieux, Marcy-l'Etoile, France) [8, 9] . This system was developed to automatically identify up to 24 microbial pathogens, including 19 bacterial genera/species and five Candida species, as well as the genes mecA, Van A/B and bla (KPC). Notably, this innovative system can successfully detect causative pathogens with the use of blood culture bottles before positive results can be obtained with conventional culture protocols [10] . In fact, one previous study demonstrated retrospectively that the detection rate of BCID with positive blood culture bottles was around 95 %, and the analysis of prospectively collected blood culture specimens showed that the panel's pathogen coverage rate was 91 % [8] . Therefore, in addition to reducing the high initial costs of both equipment and maintenance, improving the coverage of pathogens remains a challenge.
As an innovative species-level identification method for pathogens based on the genome sequencing approach, the MinION nanopore sequencer (Oxford Nanopore Technologies [ONT], Oxford, UK), which is a small, pocket-sized device operated from a laptop connected via USB 3.0, has also been introduced in various clinical settings [11, 12] . The key innovations of the MinION platform include substantially reduced initial and operational costs and realtime sequencing, as opposed to next-generation sequencing (NGS) and Sanger sequencing [13] . In 2017, ONT released a new 1D 2 method with a modal accuracy of >97 %, which is higher than the single-read accuracy of the standard 1D method (https://nanoporetech.com/), and 1D 2 analysis tools are continually being developed to further improve sequencing. In 2018, ONT announced a new MinION flowcell model with a quarter of the number of channels, making it the most accessible and cost-efficient sequencing system for smaller analytical procedures. These innovations could promote the clinical application of NGS and would have potential as a breakthrough technology against infectious diseases in the near future.
In this study, we aimed to evaluate the application of Min-ION nanopore sequencing for the identification of the most dominant pathogens in positive blood culture bottles derived from BSI patients.
METHODS
Clinical samples and reference strains Clinical samples were obtained from positive blood culture bottles continuously monitored with a BD BACTEC FX system (Becton Dickinson and Company, Franklin Lakes, NJ) in BD BACTECTM Plus Aerobic and Anaerobic medium (Becton Dickinson). The bottles were inoculated until they were positive in culture for up to a maximum of 7 days. Each aliquot of 250 µl derived from positive blood culture medium was stored at À80 C until use. Subsequently, each aliquot was subcultured overnight on an agar plate at 37 C to isolate single colonies from positive culture bottles prior to further processing, and MALDI-TOF MS (Bruker Daltonics GmbH, Bremen, Germany) with Biotyper Real Time Classification software v3.1 (Bruker Daltonics GmbH) was performed to identify the isolates, according to the manufacturer's instructions [14] . Finally, the species with the highest score was selected when one or more species of bacteria with scores >2.0 were identified.
DNA extraction from clinical samples
A DNA extraction protocol combining glass bead-beating and chemical lysis was used as follows. First, 250 µl of each aliquot was mixed with 750 µl of Bead Solution attached to the QIAamp PowerFecal DNA Kit (Qiagen, Hilden, Germany). Then, 60 µl of Solution C1 was added to each mixture and incubated at 65 C for 10 min. Second, 0.2 g of 0.1 mm glass beads (Tomy, Tokyo, Japan) was subsequently added and the mixture was vigorously vortexed six times with Micro Smash (Tomy) at 5000 r.p.m. for 30 s. DNA purification steps were performed with QIAamp PowerFecal DNA Kit according to the manufacturers' instructions, and purified DNA was eluted with 100 µl of distilled water from the silica Spin Filter membrane. Finally, the yield of extracted DNA was estimated using the High Sensitivity DNA Kit and Qubit 2.0 fluorometer (Thermo Fisher Scientific, Waltham, MA, USA). To validate the accuracy of the sequencing analysis using our protocol, we also examined six types of reference bacteria and five fungi isolated by the National BioResource Project (http://www.nbrp.jp/) as follows: Staphylococcus aureus (JNBP 05279), Streptococcus epidermidis (JNBP 05336), Escherichia coli (JNBP 02019), Klebsiella pneumoniae (JNBP 02775), Pseudomonas aeruginosa (JNBP 04211), Burkholderia pseudomallei (JNBP 01429), Candida albicans (IFN 4949), C. glabrata (IFN 5489), C. krusei (IFN 5462), C. parapsilosis (IFN 5464) and C. tropicalis (IFN 5446). Each purified genomic DNA was suspended in 1ÂTE, and the final concentration was adjusted to 1.0 ng µl À1 to create templates for the subsequent PCR steps.
PCR reactions
The oligonucleotide PCR primer pair 27F (5¢-AGA GTT TGA TCC TGG CTC AG-3¢) and 1,492R (5¢-TAC GGY TAC CTT GTT ACG ACT T-3¢) for the detection of bacterial 16S rRNA was adopted based on a previous report [15] . Additionally, to obtain accurate identification of the fungal pathogens using a sequence-based approach, we used PCR primer pair ITS5-F (5¢-GGA AGT AAA AGT CGT AAC AAG G-3¢) and NL4-R (5¢-GGT CCG TGT TTC AAG ACG G-3¢) targeting the internal transcribed spacer 1 (ITS1)-5.8S-ITS2 rRNA gene [16] . Furthermore, to reduce the analytical cost of multiplex MinION sequencing, an ONT-specific barcode tag for the MinION was added to the start of each forward primer (27F and ITS5-F) with spacer sequences (Tables 1 and S1 , available in the online version of this article). PCR amplicons were generated by Premix Ex Taq Hot Start Version (Takara Bio Inc., Kusatsu, Japan) and thermal cycling was carried out under the following conditions: 98 C for 10 s, followed by 30 cycles at 98 C for 10 s, 55 C for 30 s and 72 C for 90 s, and a final extension at 72 C for 5 min using the same conditions for both 16S rRNA and ITS1-5.8S-ITS2 rRNA gene amplifications. Finally, each PCR product was purified with Agencourt AMPure XP (Beckman Coulter, Brea, CA, USA) according to the manufacturer's instructions and stored at À30 C until use. Fig. 1 . shows the workflow diagram with the time required and analytical pipeline for the multiplex amplicon sequencing performed in this study. Each PCR amplicon (300 ng) was processed for ligation of the 1D 2 adapter and sequencing adapters following preparation of the DNA ends for adapter attachment using the 1D 2 sequencing kit (SQK-LSK308; ONT) according to the manufacturer's instructions. After MinION Platform QC runs, the DNA library was loaded into MinION Flow Cell (FLO-MIN107) at up to 12 samples on a single flow cell, and the 'NC_48 h_sequencing_FLO-MIN107_SQK-LSK308_plus_Basecaller' protocol was initiated using the MinKNOW ONT software.
MinION sequencing

Analysis of MinION sequencing data
The 'pass' reads were obtained at 4000 MinION reads, which equated to about 10 min after starting. Additional 'pass' reads were obtained after 48 h sequencing. The reads were used for the following analysis with MinKNOW software (v.18.01.6), respectively. Porechop (v 0.2.3) was used to remove adaptors and de-multiplex the 'pass' fastq reads, and consensus sequences were constructed using Canu (v.1.7). Finally, the consensus sequences of 16S rRNA and ITS1-5.8S-ITS2 rRNA genes were applied to BlastN programs for similarity searching against the NCBI nucleotide collection (nr/nr) database.
Sanger sequencing and comparison to MinION sequencing results
The Sanger method was simultaneously applied to sequence PCR amplicons to validate the results of the corresponding amplicons sequenced from clinical specimens and type strains via the MinION sequencer. Briefly, the PCR amplicons purified by Agencourt AMPure XP (Beckman Coulter) were directly sequenced with each primer: 27F or 1492R for 16S rRNA, ITS5-F and NL4-R for ITS1-5.8S-ITS2 rRNA. Sanger sequencing was performed by Eurofins Genomics Co., Ltd. (Tokyo, Japan).
RESULTS
PCR amplification and sequencing with the Sanger method Clinical samples (n=12) were obtained from positive blood bottles continuously monitored by the BD BACTEC FX system and confirmed at the genus level via MALDI-TOF MS. However, three clinical samples were excluded because ethical consent could not be obtained. Therefore, after 11 reference strains were added, the PCR reactions were carried out using a total of 20 samples. Finally, the PCR amplicons were successfully obtained using one of the primer sets with an ONT-specific barcode tag, either 16S rRNA or ITS1-5.8S-ITS2 rRNA, and continuous sequence analysis was performed on each PCR product by the Sanger method. Approximately 1400 base sequences were obtained for each 16S rRNA amplicon, and about 1000 base sequences for each ITS1-5.8S-ITS2 rRNA amplicon, while C. glabrata had 1400 base sequences. Tables 2 and 3 (Tables 2 and 3 ). The reason why MinION causes nucleotide deletions in the sequences of repetitive nucleotides is that it analyses the change in voltage across the polymer membrane caused by the ionic current passing through its nanopores [17] .
MinION sequencing and species confirmation
DISCUSSION
In this study, we evaluated 16S rRNA/ITS amplicon sequencing with the MinION nanopore sequencer and demonstrated the potential application of the sequencer in the clinical laboratory setting. The ability to rapidly sequence amplicons via a small and mobile, maintenance-free, lowcost and multiplex platform is attractive for most clinical situations. In particular, both BSI and Candida spp., which are major causative pathogens associated with high rates of morbidity and mortality, could be identified within around 10 min of sequencing. Therefore, our procedure can provide physicians with valuable information on a spectrum of pathogens to aid in the selection of antibacterial and antifungal drugs in the empirical treatment of BSI.
The detection protocol based on nucleic acid amplification test (NAAT) shows good potential for the development of an early method of diagnosis for BSI; however, the small amount of pathogenic DNA and the presence of various PCR inhibitors in blood culture bottles substantially influence the results of PCR amplification [18] . PCR inhibitors commonly found include blood-derived heme compounds, heparin, EDTA, polyacetal sulfonate contained in the culture media, large amounts of human DNA, and polysaccharides derived from bacteria [19, 20] . In addition, the cell walls of Gram-positive cocci contain high proportions of pentaglycine and these are resistant to surfactants such as sodium dodecyl sulfate and to pretreatment with proteinase K [21] . In this study, with the successful extraction and purification of DNA using the QIAamp PowerFecal DNA Kit combined with pretreatment with bead-beating, amplification products were obtained from all culture-positive specimens.
In our protocol, we obtained sufficient depth of coverage (100-200 fold) for each barcoded specimen with high sequence accuracy in a sequencing run of around 10 min, which provided 4000 reads among the 12 specimens. Further extension of the sequence run time could allow accumulation of the sequence coverage but would not improve sequence accuracy. Successful multiplex sequencing for more than 12 barcoded specimens would require an extension of the run time. In the case of fewer specimens, this could be shortened but the cost performance of sequencing would deteriorate. In the near future, a low-price Flongle Flow Cell will become available (https://nanoporetech.com/ products/flongle). This is an adapter for the MinION for Of course, it is clear that our sequence analysis and confirmation protocol targeting the most dominant pathogens using the consensus sequences obtained could not address mixed polymicrobial infections or contamination within the culture bottles. However, it was noteworthy that our protocol identified each pathogen in a mixed BSI caused by a bacterium and Candida spp., which often results in septic shock and multiple organ failure and has a poor prognosis [22] . In particular, culture-negative specimens with or without clear evidence of infection could become PCR positive because of various factors excepting environmental contamination; for example, the presence of difficult-to-culture pathogens, previous antibiotic therapy and contamination of bacterial DNA in Taq DNA polymerase. However, from a clinical point of view, it is also important to detect causative pathogens from culture-negative specimens. Further investigations are required to assess culture-negative and PCR-positive specimens based on amplicon sequencing with MinION.
Unfortunately, it is also evident that the 16S rRNA sequence in bacterial taxonomy cannot be inherently distinguished among closely related species [23, 24] . In our study, samples 4 and 6 were misidentified as Streptococcus dysgalactiae and Shigella dysenteriae, respectively, in the first 4000 MinION leads. However, these errors are thought to have been caused by the limitations of 16S rRNA sequencing and not to a specific sequencing error of the MinION [25] . In fact, Pupo et al. demonstrated that sequence analysis based on variations in the housekeeping genes of most Shigella serotypes and Escherichia coli fails to distinguish one from the other [26] . It is therefore necessary to keep in mind that this protocol still struggles to accurately assign isolates specific to a particular species.
To date, several publications have evaluated the capability of MinION to identify pathogens, perform strain typing and identify drug-resistant genes via a whole-genome sequencing (WGS) approach [17, [27] [28] [29] . This WGS strategy relies on the MinION's main advantage, which is that it can output long reads. However, the evidence of its ability to identify strains in positive culture bottles from BSI patients remains limited. Anson et al. showed that contamination by human genes of input bacterial genes reduces the coverage of bacterial sequences obtained with MinION, which can complicate accurate identification of bacterial species from positive blood culture bottles [27, 28, 30] . Additionally, drug resistance associated with genetic mutations or single nucleotide polymorphisms, such as fluoroquinolone resistance, is difficult to determine in the MinION pipeline because the error rate of the MinION reads is higher than that of corresponding Illumina or Sanger sequencing reads [27, 28] . WGS without PCR amplification is an ideal and promising scheme for clinical laboratories, but MinION requires further improvements and an analytical pipeline.
In our study, we used the 1D 2 method with a R9.5 flow cell, which can produce higher accuracy reads than 1D alone or the 2D method; however, the average rate of sequence identity remained around 99 %. Moreover, even when the sequencing time of MinION was extended from around 10 min to 48 h, there was no significant improvement in the accuracy rate. This was because 1D 2 sequencing contained deletion errors more frequently around homopolymer sequences, which did not affect species identification based on 16S rRNA sequencing, regardless of the sequencing time. Previously, Benítez-P aez et al. demonstrated that MinION sequencing of 16S rRNA gene amplicons was valuable for both high taxonomic resolution and the analysis of microbial diversity [31] . Despite using the R7.3 flow cell and 2D chemistry (SQK-MAP-005, ONT), they showed that acceptable taxonomic classification of 20 different bacteria can be achieved. Further evidence using clinical samples and continued improvement of this novel sequencing technology, including the development of a pipeline for data analysis, is needed; however, traditional 16S rRNA sequencing combined with novel MinION nanopore sequencer technology could become a promising and reliable scheme in the near future.
In conclusion, we established a rapid, portable and economical technology for the identification of pathogens in positive blood culture bottles through an amplicon sequencing scheme using the MinION nanopore sequencer. This technology could become an innovative NAAT for application in various medical environments. We proposed this technology because it can improve morbidity and mortality prognoses among BSI patients and promote the antimicrobial resistance agenda by contributing to antibiotic stewardship in clinical settings.
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